Showing results (201-210 of 580) with videos related to
Sort By:
Pageof 58
Plos One|June 18, 2015
Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)Hanyong Chen, Ke Yao, Xiaoyu Chang, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2011
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1Darya V Urusova, Jung-Hyun Shim, Dong Joon Kim, et al.Gene|December 23, 2008
Gene expression analysis of terminal differentiation of human melanoma cells highlights global reductions in cell cycle-associated genesKim Mai Huynh, Gyoungmi Kim, Dong-Joon Kim, et al.Journal of Clinical Neurology (Seoul, Korea)|March 10, 2015
Recurrent Cardioembolic Stroke Treated Successfully with Repeated Mechanical Thrombectomy within the Acute Index Stroke PeriodYoonju Lee, Han Yi, Byoung Moon Kim, et al.Journal of Cancer|June 7, 2021
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived XenograftsFayang Ma, Kyle Laster, Wenna Nie, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.Cellular and Molecular Life Sciences : CMLS|August 30, 2023
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancerXiaomeng Xie, Kyle Vaughn Laster, Jian Li, et al.Cellular Oncology (Dordrecht, Netherlands)|February 1, 2022
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinomaXiangyu Wang, Xiaomeng Xie, Yuanyuan Zhang, et al.Journal of Cancer|June 17, 2022
3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivoFayang Ma, Fangfang Liu, Wenna Nie, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 19, 2021
EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathwayHui Liu, Mangaladoss Fredimoses, Peijia Niu, et al.Pageof 58